Digital Pathology Devices Can Now Be Used Remotely Under Emergency FDA Guidance
The immediately-in-effect guidance document says devices to review digital pathology slides can be modified so they can be used outside a laboratory or health care setting, and allows remote digital pathology devices that have not been 510(k)-cleared to be marketed while the US fights the COVID-19 pandemic.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Consensus report CR511 from the Association for the Advancement of Medical Instrumentation highlights common system elements for engineers, and outlines safety and risk-control measures that manufacturers and caregivers should consider.
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.